Share

Arroyo, Vicente es

List of all publications

Publishing since 1973 (Dinosaur)

    2010

  1. Journal Article Padrissa-Altés S, Zaouali MA, Franco-Gou R, Bartrons R, Boillot O, Rimola A, Arroyo V, Rodés J, Peralta C, Roselló-Catafau J. Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix.  Am. J. Transplant.  2010;10;5  Link to Matrix metalloproteinase 2 in reduced-size liver transplantation: beyond the matrix.
  2. Journal Article Horrillo R, González-Périz A, Martínez-Clemente M, López-Parra M, Ferré N, Titos E, Morán-Salvador E, Deulofeu R, Arroyo V, Clària J. 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.  J. Immunol.  2010;184;7  Link to 5-lipoxygenase activating protein signals adipose tissue inflammation and lipid dysfunction in experimental obesity.
  3. Journal ArticleResearch Support, N.I.H., Extramural Moreno M, Gonzalo T, Kok RJ, Sancho-Bru P, van Beuge M, Swart J, Prakash J, Temming K, Fondevila C, Beljaars L, Lacombe M, van der Hoeven P, Arroyo V, Poelstra K, Brenner DA, Ginès P, Bataller R. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.  Hepatology  2010;51;3  Link to Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats.
  4. Journal Article Moreno M, Chaves JF, Sancho-Bru P, Ramalho F, Ramalho LN, Mansego ML, Ivorra C, Dominguez M, Conde L, Millán C, Marí M, Colmenero J, Lozano JJ, Jares P, Vidal J, Forns X, Arroyo V, Caballería J, Ginès P, Bataller R. Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans.  Hepatology  2010;51;3  Link to Ghrelin attenuates hepatocellular injury and liver fibrogenesis in rodents and influences fibrosis progression in humans.
  5. Journal Article Martínez-Clemente M, Ferré N, González-Périz A, López-Parra M, Horrillo R, Titos E, Morán-Salvador E, Miquel R, Arroyo V, Funk CD, Clària J. 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.  Hepatology  2010;51;3  Link to 5-lipoxygenase deficiency reduces hepatic inflammation and tumor necrosis factor alpha-induced hepatocyte damage in hyperlipidemia-prone ApoE-null mice.
  6. Journal ArticleResearch Support, N.I.H., Extramural Sancho-Bru P, Juez E, Moreno M, Khurdayan V, Morales-Ruiz M, Colmenero J, Arroyo V, Brenner DA, Ginès P, Bataller R. Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells.  Liver Int.  2010;30;1  Link to Hepatocarcinoma cells stimulate the growth, migration and expression of pro-angiogenic genes in human hepatic stellate cells.
  7. Journal Article Nazar A, Pereira GH, Guevara M, Martín-Llahi M, Pepin MN, Marinelli M, Solá E, Baccaro ME, Terra C, Arroyo V, Ginès P. Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.  Hepatology  2010;51;1  Link to Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.

    8. 2009

  8. CommentEditorial Arroyo V. Human serum albumin: not just a plasma volume expander.  Hepatology  2009;50;2  Link to Human serum albumin: not just a plasma volume expander.
  9. Journal Article Colmenero J, Bataller R, Sancho-Bru P, Dominguez M, Moreno M, Forns X, Bruguera M, Arroyo V, Brenner DA, Ginès P. Effects of Losartan on Hepatic Expression of Non-phagocytic NADPH Oxidase and Fibrogenic Genes in Patients with Chronic Hepatitis C.  Am. J. Physiol. Gastrointest. Liver Physiol.  2009  Link to Effects of Losartan on Hepatic Expression of Non-phagocytic NADPH Oxidase and Fibrogenic Genes in Patients with Chronic Hepatitis C.
  10. Comparative StudyJournal Article Guevara M, Baccaro ME, Torre A, Gómez-Ansón B, Ríos J, Torres F, Rami L, Monté-Rubio GC, Martín-Llahí M, Arroyo V, Ginès P. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.  Am. J. Gastroenterol.  2009;104;6  Link to Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
  11. Journal Article Dominguez M, Miquel R, Colmenero J, Moreno M, García-Pagán JC, Bosch J, Arroyo V, Ginès P, Caballería J, Bataller R. Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.  Gastroenterology  2009;136;5  Link to Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis.
  12. Journal Article Ferré N, Martínez-Clemente M, López-Parra M, González-Périz A, Horrillo R, Planagumà A, Camps J, Joven J, Tres A, Guardiola F, Bataller R, Arroyo V, Clària J. Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols.  Am. J. Physiol. Gastrointest. Liver Physiol.  2009;296;3  Link to Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols.
  13. Journal Article Padrissa-Altés S, Franco-Gou R, Boillot O, Serafín A, Rimola A, Arroyo V, Rodés J, Peralta C, Roselló-Catafau J. Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.  Liver Transpl.  2009;15;3  Link to Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation.
  14. Journal Article Moreno M, Ramalho LN, Sancho-Bru P, Ruiz-Ortega M, Ramalho F, Abraldes JG, Colmenero J, Dominguez M, Egido J, Arroyo V, Ginès P, Bataller R. Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.  Am. J. Physiol. Gastrointest. Liver Physiol.  2009;296;2  Link to Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver.
  15. Editorial Arroyo V, Piqué JM. [Changes in "Gastroenterology and Hepatology"]  Gastroenterol Hepatol  2009;32;1  Link to [Changes in "Gastroenterology and Hepatology"]

    16. 2008

  16. Journal Article Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.  Postgrad Med J  2008;84;998  Link to Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
  17. Journal Article López-Parra M, Titos E, Horrillo R, Ferré N, González-Périz A, Martínez-Clemente M, Planagumà A, Masferrer J, Arroyo V, Clària J. Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.  J. Lipid Res.  2008;49;12  Link to Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice.
  18. Journal Article Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R, Arroyo V, Caballería J, Ginès P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis.  Am. J. Gastroenterol.  2008;103;11  Link to A new scoring system for prognostic stratification of patients with alcoholic hepatitis.
  19. English AbstractJournal ArticleReview Fernández J, Fernández-Balsells M, Acevedo J, Arroyo V. [Adrenal insufficiency in cirrhosis]  Gastroenterol Hepatol  2008;31;9  Link to [Adrenal insufficiency in cirrhosis]
  20. Journal Article Clemente Ricote G, Pérez-Lázaro JJ, Tejedor M, Planas R, de la Mata M, Córdoba J, Jara P, Herrero JI, Prieto M, Suárez G, Arroyo V. [The Spanish System of Accreditation of Professional Competencies in Hepatology. A proposal of the Spanish Association for the Study of the Liver]  Gastroenterol Hepatol  2008;31;8  Link to [The Spanish System of Accreditation of Professional Competencies in Hepatology. A proposal of the Spanish Association for the Study of the Liver]
  21. Journal Article Principe A, Melgar-Lesmes P, Fernández-Varo G, del Arbol LR, Ros J, Morales-Ruiz M, Bernardi M, Arroyo V, Jiménez W. The hepatic apelin system: a new therapeutic target for liver disease.  Hepatology  2008;48;4  Link to The hepatic apelin system: a new therapeutic target for liver disease.
  22. English AbstractJournal Article Clemente G, Pérez-Lázaro JJ, Tejedor M, Planas R, De la Mata M, Córdoba J, Jara P, Herrero JI, Prieto M, Suáreza G, Arroyo V. [Accreditation of processes in hepatology]  Gastroenterol Hepatol  2008;31;7  Link to [Accreditation of processes in hepatology]
  23. CommentLetter Arroyo V, Fernandez J, Mas A, Escorsell A. Molecular adsorbents recirculating system (MARS) and the failing liver: a negative editorial for a positive trial?  Hepatology  2008;47;6  Link to Molecular adsorbents recirculating system (MARS) and the failing liver: a negative editorial for a positive trial?
  24. Journal ArticleReview Sanyal AJ, Bosch J, Blei A, Arroyo V. Portal hypertension and its complications.  Gastroenterology  2008;134;6  Link to Portal hypertension and its complications.
  25. Comparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Martín-Llahí M, Pépin MN, Guevara M, Díaz F, Torre A, Monescillo A, Soriano G, Terra C, Fábrega E, Arroyo V, Rodés J, Ginès P. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.  Gastroenterology  2008;134;5  Link to Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
  26. Journal ArticleReview Arroyo V, Fernandez J, Ginès P. Pathogenesis and treatment of hepatorenal syndrome.  Semin. Liver Dis.  2008;28;1  Link to Pathogenesis and treatment of hepatorenal syndrome.

    27. 2007

  27. Journal ArticleResearch Support, N.I.H., Extramural Tugues S, Fernandez-Varo G, Muñoz-Luque J, Ros J, Arroyo V, Rodés J, Friedman SL, Carmeliet P, Jiménez W, Morales-Ruiz M. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.  Hepatology  2007;46;6  Link to Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
  28. Journal ArticleResearch Support, N.I.H., Extramural Sancho-Bru P, Bataller R, Fernandez-Varo G, Moreno M, Ramalho LN, Colmenero J, Marí M, Clària J, Jiménez W, Arroyo V, Brenner DA, Ginès P. Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.  Gastroenterology  2007;133;6  Link to Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.
  29. Journal ArticleRandomized Controlled Trial Fernández J, Navasa M, Planas R, Montoliu S, Monfort D, Soriano G, Vila C, Pardo A, Quintero E, Vargas V, Such J, Ginès P, Arroyo V. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.  Gastroenterology  2007;133;3  Link to Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.
  30. Journal Article Londoño MC, Cárdenas A, Guevara M, Quintó L, de Las Heras D, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Ginès P. MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.  Gut  2007;56;9  Link to MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.
  31. Journal ArticleReview Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.  Gut  2007;56;9  Link to Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.
  32. Journal ArticleReview Arroyo V, Terra C, Ginès P. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.  J. Hepatol.  2007;46;5  Link to Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
  33. Journal Article Morales-Ruiz M, Fondevila C, Muñoz-Luque J, Tugues S, Rodríguez-Laiz G, Cejudo-Martín P, Romero JM, Navasa M, Fuster J, Arroyo V, Sessa WC, García-Valdecasas JC, Jiménez W. Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantation.  Am. J. Transplant.  2007;7;4  Link to Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantation.
  34. Clinical TrialLetterMulticenter Study Sigal SH, Stanca CM, Fernandez J, Arroyo V, Navasa M. Restricted use of albumin for spontaneous bacterial peritonitis.  Gut  2007;56;4  Link to Restricted use of albumin for spontaneous bacterial peritonitis.
  35. Journal Article Fernández-Varo G, Morales-Ruiz M, Ros J, Tugues S, Muñoz-Luque J, Casals G, Arroyo V, Rodés J, Jiménez W. Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.  J. Hepatol.  2007;46;3  Link to Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.
  36. Journal Article Colmenero J, Bataller R, Sancho-Bru P, Bellot P, Miquel R, Moreno M, Jares P, Bosch J, Arroyo V, Caballería J, Ginès P. Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.  Gastroenterology  2007;132;2  Link to Hepatic expression of candidate genes in patients with alcoholic hepatitis: correlation with disease severity.
  37. Journal ArticleReview Cárdenas A, Arroyo V. Management of ascites and hepatic hydrothorax.  Best Pract Res Clin Gastroenterol  2007;21;1  Link to Management of ascites and hepatic hydrothorax.

    38. 2006

  38. Journal Article Esteva-Font C, Baccaro ME, Fernández-Llama P, Sans L, Guevara M, Ars E, Jiménez W, Arroyo V, Ballarín JA, Ginès P. Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.  Hepatology  2006;44;6  Link to Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.
  39. Journal ArticleResearch Support, N.I.H., Extramural Sancho-Bru P, Bataller R, Colmenero J, Gasull X, Moreno M, Arroyo V, Brenner DA, Ginès P. Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells.  Am. J. Physiol. Gastrointest. Liver Physiol.  2006;291;5  Link to Norepinephrine induces calcium spikes and proinflammatory actions in human hepatic stellate cells.
  40. Comparative StudyControlled Clinical TrialJournal Article Fernández J, Escorsell A, Zabalza M, Felipe V, Navasa M, Mas A, Lacy AM, Ginès P, Arroyo V. Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.  Hepatology  2006;44;5  Link to Adrenal insufficiency in patients with cirrhosis and septic shock: Effect of treatment with hydrocortisone on survival.
  41. Comparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Fernández J, Ruiz del Arbol L, Gómez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.  Gastroenterology  2006;131;4  Link to Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
  42. Journal Article Arroyo V. [Presentation.]  Gastroenterol Hepatol  2006;29 Suppl 2  Link to [Presentation.]
  43. Journal ArticleReview Arroyo V, Terra C, Ginès P. New treatments of hepatorenal syndrome.  Semin. Liver Dis.  2006;26;3  Link to New treatments of hepatorenal syndrome.
  44. Journal Article López-Parra M, Telleria N, Titos E, Planagumà A, González-Périz A, Arroyo V, Rodés J, Clària J. Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.  J. Hepatol.  2006;45;2  Link to Gene expression profiling of renal dysfunction in rats with experimental cirrhosis.
  45. Journal Article Londoño MC, Guevara M, Rimola A, Navasa M, Taurà P, Mas A, García-Valdecasas JC, Arroyo V, Ginès P. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.  Gastroenterology  2006;130;4  Link to Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.

    46. 2005

  46. Journal Article Terra C, Guevara M, Torre A, Gilabert R, Fernández J, Martín-Llahí M, Baccaro ME, Navasa M, Bru C, Arroyo V, Rodés J, Ginès P. Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.  Gastroenterology  2005;129;6  Link to Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score.
  47. Journal Article Tugues S, Morales-Ruiz M, Fernandez-Varo G, Ros J, Arteta D, Muñoz-Luque J, Arroyo V, Rodés J, Jiménez W. Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats.  Gastroenterology  2005;129;5  Link to Microarray analysis of endothelial differentially expressed genes in liver of cirrhotic rats.
  48. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.  Hepatology  2005;42;3  Link to A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.
  49. Journal Article Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, Milicua JM, Jiménez W, Arroyo V. Circulatory function and hepatorenal syndrome in cirrhosis.  Hepatology  2005;42;2  Link to Circulatory function and hepatorenal syndrome in cirrhosis.
  50. Comparative StudyIn VitroJournal Article Sancho-Bru P, Bataller R, Gasull X, Colmenero J, Khurdayan V, Gual A, Nicolás JM, Arroyo V, Ginès P. Genomic and functional characterization of stellate cells isolated from human cirrhotic livers.  J. Hepatol.  2005;43;2  Link to Genomic and functional characterization of stellate cells isolated from human cirrhotic livers.
  51. Journal Article Morales-Ruiz M, Tugues S, Cejudo-Martín P, Ros J, Melgar-Lesmes P, Fernández-Llama P, Arroyo V, Rodés J, Jiménez W. Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway.  J. Hepatol.  2005;43;1  Link to Ascites from cirrhotic patients induces angiogenesis through the phosphoinositide 3-kinase/Akt signaling pathway.
  52. Journal Article Alessandria C, Ozdogan O, Guevara M, Restuccia T, Jiménez W, Arroyo V, Rodés J, Ginès P. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.  Hepatology  2005;41;6  Link to MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
  53. Comparative StudyJournal Article Angeli P, Fernández-Varo G, Dalla Libera V, Fasolato S, Galioto A, Arroyo V, Sticca A, Guarda S, Gatta A, Jiménez W. The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites.  Liver Int.  2005;25;2  Link to The role of nitric oxide in the pathogenesis of systemic and splanchnic vasodilation in cirrhotic rats before and after the onset of ascites.
  54. Journal Article Domenicali M, Ros J, Fernández-Varo G, Cejudo-Martín P, Crespo M, Morales-Ruiz M, Briones AM, Campistol JM, Arroyo V, Vila E, Rodés J, Jiménez W. Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.  Gut  2005;54;4  Link to Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors.
  55. Clinical TrialJournal ArticleRandomized Controlled Trial Clària J, Kent JD, López-Parra M, Escolar G, Ruiz-Del-Arbol L, Ginès P, Jiménez W, Vucelic B, Arroyo V. Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.  Hepatology  2005;41;3  Link to Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites.
  56. Journal ArticleReview Arroyo V, Terra C, Torre A. [Circulatory support with albumin in liver cirrhosis]  Gastroenterol Hepatol  2005;28;2  Link to [Circulatory support with albumin in liver cirrhosis]
  57. Journal ArticleReview Arroyo V, Torre A, Guevara M. Recent advances in hepatorenal syndrome.  Trop Gastroenterol  2005;26;1  Link to Recent advances in hepatorenal syndrome.
  58. Journal ArticleReview Cárdenas A, Arroyo V. Refractory ascites.  Dig Dis  2005;23;1  Link to Refractory ascites.
  59. Journal Article López-Parra M, Clària J, Titos E, Planagumà A, Párrizas M, Masferrer JL, Jiménez W, Arroyo V, Rivera F, Rodés J. The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin.  J. Hepatol.  2005;42;1  Link to The selective cyclooxygenase-2 inhibitor celecoxib modulates the formation of vasoconstrictor eicosanoids and activates PPARgamma. Influence of albumin.

    60. 2004

  60. Comparative StudyJournal Article Mata A, Bordas JM, Llach J, Ginés A, Mondelo F, Lopez Serrano A, Valdecasas JC, Piquè JM, Arroyo V. ERCP in orthotopic liver transplanted patients.  Hepatogastroenterology  2004;51;60  Link to ERCP in orthotopic liver transplanted patients.
  61. Journal Article Arroyo V, Clemente G. [Presentation.]  Gastroenterol Hepatol  2004;27 Suppl 4  Link to [Presentation.]
  62. Clinical TrialJournal Article Fernández J, Navasa M, Garcia-Pagan JC, G-Abraldes J, Jiménez W, Bosch J, Arroyo V. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.  J. Hepatol.  2004;41;3  Link to Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis.
  63. Journal Article Guevara M, Fernández-Esparrach G, Alessandria C, Torre A, Terra C, Montañà X, Piera C, Alvarez ML, Jiménez W, Ginès P, Arroyo V. Effects of contrast media on renal function in patients with cirrhosis: a prospective study.  Hepatology  2004;40;3  Link to Effects of contrast media on renal function in patients with cirrhosis: a prospective study.
  64. Journal ArticleReview Arroyo V. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.  Aliment. Pharmacol. Ther.  2004;20 Suppl 3  Link to Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
  65. Journal Article Restuccia T, Gómez-Ansón B, Guevara M, Alessandria C, Torre A, Alayrach ME, Terra C, Martín M, Castellví M, Rami L, Sainz A, Ginès P, Arroyo V. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.  Hepatology  2004;39;6  Link to Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis.
  66. Journal ArticleReview Ginès P, Cárdenas A, Arroyo V, Rodés J. Management of cirrhosis and ascites.  N. Engl. J. Med.  2004;350;16  Link to Management of cirrhosis and ascites.
  67. Journal Article Ramírez MJ, Ibáñez A, Navasa M, Casals E, Morales-Ruiz M, Jiménez W, Arroyo V, Rodés J. High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites.  J. Hepatol.  2004;40;3  Link to High-density lipoproteins reduce the effect of endotoxin on cytokine production and systemic hemodynamics in cirrhotic rats with ascites.
  68. Journal Article Titos E, Planagumà A, López-Parra M, Villamor N, Miquel R, Jiménez W, Arroyo V, Rivera F, Rodés J, Clària J. 5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis.  Comp Hepatol  2004;3 Suppl 1  Link to 5-Lipoxygenase (5-LO) is Involved in Kupffer Cell Survival. Possible Role of 5-LO Products in the Pathogenesis of Liver Fibrosis.
  69. Journal Article Restuccia T, Ortega R, Guevara M, Ginès P, Alessandria C, Ozdogan O, Navasa M, Rimola A, Garcia-Valdecasas JC, Arroyo V, Rodés J. Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.  J. Hepatol.  2004;40;1  Link to Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study.

    70. 2003

  70. Journal ArticleReview Cárdenas A, Arroyo V. Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.  Best Pract. Res. Clin. Endocrinol. Metab.  2003;17;4  Link to Mechanisms of water and sodium retention in cirrhosis and the pathogenesis of ascites.
  71. Journal ArticleReview Ginès P, Guevara M, Arroyo V, Rodés J. Hepatorenal syndrome.  Lancet  2003;362;9398  Link to Hepatorenal syndrome.
  72. Journal Article Ruiz-del-Arbol L, Urman J, Fernández J, González M, Navasa M, Monescillo A, Albillos A, Jiménez W, Arroyo V. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.  Hepatology  2003;38;5  Link to Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis.
  73. Journal Article Viñas O, Bataller R, Sancho-Bru P, Ginès P, Berenguer C, Enrich C, Nicolás JM, Ercilla G, Gallart T, Vives J, Arroyo V, Rodés J. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation.  Hepatology  2003;38;4  Link to Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation.
  74. CommentJournal Article Jiménez W, Arroyo V. Origins of cardiac dysfunction in cirrhosis.  Gut  2003;52;10  Link to Origins of cardiac dysfunction in cirrhosis.
  75. CommentJournal Article Arroyo V, Colmenero J. Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.  Dig Liver Dis  2003;35;9  Link to Use of albumin in the management of patients with decompensated cirrhosis. An independent verdict.
  76. Journal Article De las Heras D, Fernández J, Ginès P, Cárdenas A, Ortega R, Navasa M, Barberá JA, Calahorra B, Guevara M, Bataller R, Jiménez W, Arroyo V, Rodés J. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis.  Hepatology  2003;38;2  Link to Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis.
  77. Journal Article Piqué JM, Arroyo V, Planas R, Pérez-Mateo M, Prieto J. [Training of specialists in gastroenterology. Was it time for a review?]  Gastroenterol Hepatol  2003;26;7  Link to [Training of specialists in gastroenterology. Was it time for a review?]
  78. Journal Article Morales-Ruiz M, Cejudo-Martín P, Fernández-Varo G, Tugues S, Ros J, Angeli P, Rivera F, Arroyo V, Rodés J, Sessa WC, Jiménez W. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.  Gastroenterology  2003;125;2  Link to Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.
  79. Journal Article Bataller R, Sancho-Bru P, Ginès P, Lora JM, Al-Garawi A, Solé M, Colmenero J, Nicolás JM, Jiménez W, Weich N, Gutiérrez-Ramos JC, Arroyo V, Rodés J. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.  Gastroenterology  2003;125;1  Link to Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II.
  80. Consensus Development ConferenceJournal ArticleReview Moore KP, Wong F, Gines P, Bernardi M, Ochs A, Salerno F, Angeli P, Porayko M, Moreau R, Garcia-Tsao G, Jimenez W, Planas R, Arroyo V. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.  Hepatology  2003;38;1  Link to The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
  81. Journal Article Fernández-Varo G, Ros J, Cejudo-Martín P, Cano C, Arroyo V, Rivera F, Rodés J, Jiménez W. Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.  J. Hepatol.  2003;38;6  Link to Effect of the V1a/V2-AVP receptor antagonist, Conivaptan, on renal water metabolism and systemic hemodynamics in rats with cirrhosis and ascites.
  82. Journal Article Fernández-Varo G, Ros J, Morales-Ruiz M, Cejudo-Martín P, Arroyo V, Solé M, Rivera F, Rodés J, Jiménez W. Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.  Am. J. Pathol.  2003;162;6  Link to Nitric oxide synthase 3-dependent vascular remodeling and circulatory dysfunction in cirrhosis.
  83. Journal ArticleReview Cárdenas A, Arroyo V. Hepatorenal syndrome.  Ann Hepatol  2003;2;1  Link to Hepatorenal syndrome.
  84. Journal ArticleReview Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.  J. Hepatol.  2003;38 Suppl 1  Link to Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.
  85. CommentEditorialReview Arroyo V, Jiménez W. Clinical need for antidiuretic hormone antagonists in cirrhosis.  Hepatology  2003;37;1  Link to Clinical need for antidiuretic hormone antagonists in cirrhosis.

    86. 2002

  86. Clinical TrialComparative StudyJournal ArticleRandomized Controlled TrialResearch Support, U.S. Gov't, P.H.S. Ginès P, Uriz J, Calahorra B, Garcia-Tsao G, Kamath PS, Del Arbol LR, Planas R, Bosch J, Arroyo V, Rodés J. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.  Gastroenterology  2002;123;6  Link to Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
  87. Journal ArticleReview Ginès P, Guevara M, De Las Heras D, Arroyo V. Review article: albumin for circulatory support in patients with cirrhosis.  Aliment. Pharmacol. Ther.  2002;16 Suppl 5  Link to Review article: albumin for circulatory support in patients with cirrhosis.
  88. Journal ArticleReview Arroyo V. Review article: albumin in the treatment of liver diseases--new features of a classical treatment.  Aliment. Pharmacol. Ther.  2002;16 Suppl 5  Link to Review article: albumin in the treatment of liver diseases--new features of a classical treatment.
  89. Journal Article Cejudo-Martín P, Morales-Ruiz M, Ros J, Navasa M, Fernández-Varo G, Fuster J, Rivera F, Arroyo V, Rodés J, Jiménez W. Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients.  Hepatology  2002;36;5  Link to Hypoxia is an inducer of vasodilator agents in peritoneal macrophages of cirrhotic patients.
  90. Clinical TrialJournal Article Ortega R, Ginès P, Uriz J, Cárdenas A, Calahorra B, De Las Heras D, Guevara M, Bataller R, Jiménez W, Arroyo V, Rodés J. Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.  Hepatology  2002;36;4 Pt 1  Link to Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study.
  91. Journal ArticleReview Arroyo V, Guevara M, Ginès P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment.  Gastroenterology  2002;122;6  Link to Hepatorenal syndrome in cirrhosis: pathogenesis and treatment.
  92. Journal ArticleReview Arroyo V. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.  Ann Hepatol  2002;1;2  Link to Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
  93. Journal Article Uriz J, Ginès P, Ortega R, Jiménez W, Cárdenas A, Calahorra B, Sort P, Fernández J, Bataller R, Arroyo V, Rivera F, Rodés J. Increased plasma levels of neuropeptide Y in hepatorenal syndrome.  J. Hepatol.  2002;36;3  Link to Increased plasma levels of neuropeptide Y in hepatorenal syndrome.
  94. BiographyClassical ArticleHistorical ArticleJournal Article Arroyo V. Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure [Lancet 1956;2:1221-1225].  J. Hepatol.  2002;36;3  Link to Hecker R, Sherlock S. Electrolyte and circulatory changes in terminal liver failure [Lancet 1956;2:1221-1225].
  95. Journal Article Cárdenas A, Arroyo V. Hepatorenal syndrome-pathogenesis and treatment.  Curr Gastroenterol Rep  2002;4;1  Link to Hepatorenal syndrome-pathogenesis and treatment.
  96. Journal Article Fernández J, Navasa M, Gómez J, Colmenero J, Vila J, Arroyo V, Rodés J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.  Hepatology  2002;35;1  Link to Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
  97. Journal Article Ros J, Clària J, To-Figueras J, Planagumà A, Cejudo-Martín P, Fernández-Varo G, Martín-Ruiz R, Arroyo V, Rivera F, Rodés J, Jiménez W. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.  Gastroenterology  2002;122;1  Link to Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat.

    98. 2001

  98. Journal Article Gasull X, Bataller R, Ginès P, Sancho-Bru P, Nicolás JM, Görbig MN, Ferrer E, Badía E, Gual A, Arroyo V, Rodés J. Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide.  J. Hepatol.  2001;35;6  Link to Human myofibroblastic hepatic stellate cells express Ca(2+)-activated K(+) channels that modulate the effects of endothelin-1 and nitric oxide.
  99. Journal Article Cárdenas A, Ginès P, Uriz J, Bessa X, Salmerón JM, Mas A, Ortega R, Calahorra B, De Las Heras D, Bosch J, Arroyo V, Rodés J. Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.  Hepatology  2001;34;4 Pt 1  Link to Renal failure after upper gastrointestinal bleeding in cirrhosis: incidence, clinical course, predictive factors, and short-term prognosis.
  100. Journal Article Cejudo-Martín P, Ros J, Navasa M, Fernández J, Fernández-Varo G, Ruiz-del-Arbol L, Rivera F, Arroyo V, Rodés J, Jiménez W. Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis.  Hepatology  2001;34;3  Link to Increased production of vascular endothelial growth factor in peritoneal macrophages of cirrhotic patients with spontaneous bacterial peritonitis.
  101. Journal Article Bataller R, Gasull X, Ginès P, Hellemans K, Görbig MN, Nicolás JM, Sancho-Bru P, De Las Heras D, Gual A, Geerts A, Arroyo V, Rodés J. In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels.  Hepatology  2001;33;4  Link to In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels.
  102. Journal Article Görbig MN, Ginès P, Bataller R, Nicolás JM, Garcia-Ramallo E, Cejudo P, Sancho-Bru P, Jiménez W, Arroyo V, Rodés J. Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility.  J. Hepatol.  2001;34;2  Link to Human hepatic stellate cells secrete adrenomedullin: potential autocrine factor in the regulation of cell contractility.
  103. Journal Article Fernández-Esparrach G, Sánchez-Fueyo A, Ginès P, Uriz J, Quintó L, Ventura PJ, Cárdenas A, Guevara M, Sort P, Jiménez W, Bataller R, Arroyo V, Rodés J. A prognostic model for predicting survival in cirrhosis with ascites.  J. Hepatol.  2001;34;1  Link to A prognostic model for predicting survival in cirrhosis with ascites.

    104. 2000

  104. Journal ArticleReview Uriz J, Cárdenas A, Arroyo V. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.  Baillieres Best Pract Res Clin Gastroenterol  2000;14;6  Link to Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
  105. Journal Article Titos E, Clària J, Bataller R, Bosch-Marcé M, Ginès P, Jiménez W, Arroyo V, Rivera F, Rodés J. Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis.  Gastroenterology  2000;119;3  Link to Hepatocyte-derived cysteinyl leukotrienes modulate vascular tone in experimental cirrhosis.
  106. Journal ArticleReview Cárdenas A, Uriz J, Ginès P, Arroyo V. Hepatorenal syndrome.  Liver Transpl.  2000;4 Suppl 1  Link to Hepatorenal syndrome.
  107. Clinical TrialJournal Article Uriz J, Ginès P, Cárdenas A, Sort P, Jiménez W, Salmerón JM, Bataller R, Mas A, Navasa M, Arroyo V, Rodés J. Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.  J. Hepatol.  2000;33;1  Link to Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
  108. Journal Article Bataller R, Ginès P, Nicolás JM, Görbig MN, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells.  Gastroenterology  2000;118;6  Link to Angiotensin II induces contraction and proliferation of human hepatic stellate cells.
  109. Journal ArticleReview Bataller R, Ginès P, Arroyo V, Rodés J. Hepatorenal syndrome.  Clin Liver Dis  2000;4;2  Link to Hepatorenal syndrome.
  110. Journal Article Ginès P, Arroyo V. Is there still a need for albumin infusions to treat patients with liver disease?  Gut  2000;46;5  Link to Is there still a need for albumin infusions to treat patients with liver disease?
  111. Journal ArticleReview Cárdenas A, Bataller R, Arroyo V. Mechanisms of ascites formation.  Clin Liver Dis  2000;4;2  Link to Mechanisms of ascites formation.
  112. CommentEditorial Arroyo V. New treatments for hepatorenal syndrome.  Liver Transpl.  2000;6;3  Link to New treatments for hepatorenal syndrome.
  113. Journal Article Angeli P, Jiménez W, Veggian R, Fasolato S, Volpin R, MacHenzie HS, Craighero R, Libera VD, Sticca A, Arroyo V, Gatta A. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.  Hepatology  2000;31;2  Link to Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
  114. Journal ArticleReview Arroyo V, Jiménez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.  J. Hepatol.  2000;32;1 Suppl  Link to Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.

    115. 1999

  115. Journal Article Jiménez W, Ros J, Morales-Ruiz M, Navasa M, Solé M, Colmenero J, Sort P, Rivera F, Arroyo V, Rodés J. Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients.  Hepatology  1999;30;3  Link to Nitric oxide production and inducible nitric oxide synthase expression in peritoneal macrophages of cirrhotic patients.
  116. Clinical TrialJournal ArticleRandomized Controlled Trial Sort P, Navasa M, Arroyo V, Aldeguer X, Planas R, Ruiz-del-Arbol L, Castells L, Vargas V, Soriano G, Guevara M, Ginès P, Rodés J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.  N. Engl. J. Med.  1999;341;6  Link to Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
  117. Journal Article Görbig MN, Ginès P, Bataller R, Nicolás JM, Garcia-Ramallo E, Tobías E, Titos E, Rey MJ, Clària J, Arroyo V, Rodés J. Atrial natriuretic peptide antagonizes endothelin-induced calcium increase and cell contraction in cultured human hepatic stellate cells.  Hepatology  1999;30;2  Link to Atrial natriuretic peptide antagonizes endothelin-induced calcium increase and cell contraction in cultured human hepatic stellate cells.
  118. Journal ArticleReview Uriz Otano J, Sort P, Arroyo V. [Paracentesis in the treatment of ascites in cirrhotic patients]  Gastroenterol Hepatol  1999;22;7  Link to [Paracentesis in the treatment of ascites in cirrhotic patients]
  119. Journal Article Bosch-Marcè M, Clària J, Titos E, Masferrer JL, Altuna R, Poo JL, Jiménez W, Arroyo V, Rivera F, Rodés J. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.  Gastroenterology  1999;116;5  Link to Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites.
  120. Journal Article Fábregues F, Balasch J, Ginès P, Manau D, Jiménez W, Arroyo V, Creus M, Vanrell JA. Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome.  Am. J. Gastroenterol.  1999;94;4  Link to Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome.
  121. Journal Article Pérez-Ruiz M, Ros J, Morales-Ruiz M, Navasa M, Colmenero J, Ruiz-del-Arbol L, Cejudo P, Clária J, Rivera F, Arroyo V, Rodés J, Jiménez W. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.  Hepatology  1999;29;4  Link to Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: regulation by cytokines and bacterial lipopolysaccharide.
  122. Journal ArticleReview González-Abraldes J, Sánchez-Fueyo A, Arroyo V. The treatment of ascites.  Acta Gastroenterol. Belg.  1999;62;1  Link to The treatment of ascites.
  123. Journal Article Poo JL, Jiménez W, María Muñoz R, Bosch-Marcé M, Bordas N, Morales-Ruiz M, Pérez M, Deulofeu R, Solé M, Arroyo V, Rodés J. Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.  Gastroenterology  1999;116;1  Link to Chronic blockade of endothelin receptors in cirrhotic rats: hepatic and hemodynamic effects.

    124. 1998

  124. Journal Article Bataller R, Nicolás JM, Gineès P, Görbig MN, Garcia-Ramallo E, Lario S, Tobías E, Pinzani M, Thomas AP, Arroyo V, Rodés J. Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels.  J. Hepatol.  1998;29;3  Link to Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels.
  125. Journal Article Guevara M, Ginès P, Bandi JC, Gilabert R, Sort P, Jiménez W, Garcia-Pagan JC, Bosch J, Arroyo V, Rodés J. Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.  Hepatology  1998;28;2  Link to Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems.
  126. Journal Article Guevara M, Bru C, Ginès P, Fernández-Esparrach G, Sort P, Bataller R, Jiménez W, Arroyo V, Rodés None. Increased cerebrovascular resistance in cirrhotic patients with ascites.  Hepatology  1998;28;1  Link to Increased cerebrovascular resistance in cirrhotic patients with ascites.
  127. Journal Article Clària J, Titos E, Jiménez W, Ros J, Ginès P, Arroyo V, Rivera F, Rodés J. Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.  Gastroenterology  1998;115;1  Link to Altered biosynthesis of leukotrienes and lipoxins and host defense disorders in patients with cirrhosis and ascites.
  128. Journal Article Navasa M, Follo A, Filella X, Jiménez W, Francitorra A, Planas R, Rimola A, Arroyo V, Rodés J. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.  Hepatology  1998;27;5  Link to Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality.
  129. Journal Article Manau D, Balasch J, Arroyo V, Jiménez W, Fábregues F, Casamitjana R, Creus M, Vanrell JA. Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators.  J. Clin. Endocrinol. Metab.  1998;83;5  Link to Circulatory dysfunction in asymptomatic in vitro fertilization patients. Relationship with hyperestrogenemia and activity of endogenous vasodilators.
  130. Journal Article Bosch-Marcé M, Morales-Ruiz M, Jiménez W, Bordas N, Solé M, Ros J, Deulofeu R, Arroyo V, Rivera F, Rodés J. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites.  Hepatology  1998;27;5  Link to Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites.
  131. Journal Article Guevara M, Ginès P, Jiménez W, Sort P, Fernández-Esparrach G, Escorsell A, Bataller R, Bosch J, Arroyo V, Rivera F, Rodés J. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems.  Gastroenterology  1998;114;2  Link to Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems.
  132. Journal ArticleReview Bataller R, Arroyo V, Ginès P, Sort P. Hepatorenal syndrome.  Forum (Genova)  1998;8;1  Link to Hepatorenal syndrome.
  133. Journal ArticleReview Ginès P, Arroyo V, Rodés J. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.  Adv Intern Med  1998;43  Link to Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
  134. Clinical TrialControlled Clinical TrialJournal Article Guevara M, Ginès P, Fernández-Esparrach G, Sort P, Salmerón JM, Jiménez W, Arroyo V, Rodés J. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.  Hepatology  1998;27;1  Link to Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.

    135. 1997

  135. Journal Article Saló J, Fernández-Esparrach G, Ginès P, Ginès A, Guevara M, Sort P, Jiménez W, Arroyo V, Rivera F, Rodés J. Urinary endothelin-like immunoreactivity in patients with cirrhosis.  J. Hepatol.  1997;27;5  Link to Urinary endothelin-like immunoreactivity in patients with cirrhosis.
  136. English AbstractJournal Article Sort P, Ginés P, Navasa M, Arroyo V. [Current treatment of ascites and spontaneous bacterial peritonitis in Spain: analysis of a survey of gastroenterologists and hepatologists]  Gastroenterol Hepatol  1997;20;9  Link to [Current treatment of ascites and spontaneous bacterial peritonitis in Spain: analysis of a survey of gastroenterologists and hepatologists]
  137. Journal ArticleReview Bataller R, Arroyo V, Ginès P. Management of ascites in cirrhosis.  J. Gastroenterol. Hepatol.  1997;12;11  Link to Management of ascites in cirrhosis.
  138. EditorialReview Fernández-Esparrach G, Arroyo V. [Intrahepatic percutaneous portosystemic shunt and refractory ascites]  Gastroenterol Hepatol  1997;20;9  Link to [Intrahepatic percutaneous portosystemic shunt and refractory ascites]
  139. Journal Article Saló J, Ginès A, Ginès P, Piera C, Jiménez W, Guevara M, Fernández-Esparrach G, Sort P, Bataller R, Arroyo V, Rodés J. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis.  J. Hepatol.  1997;27;4  Link to Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis.
  140. Journal ArticleReview Bataller R, Ginès P, Arroyo V. Practical recommendations for the treatment of ascites and its complications.  Drugs  1997;54;4  Link to Practical recommendations for the treatment of ascites and its complications.
  141. Journal Article Bataller R, Nicolás JM, Ginès P, Esteve A, Nieves Görbig M, Garcia-Ramallo E, Pinzani M, Ros J, Jiménez W, Thomas AP, Arroyo V, Rodés J. Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.  Gastroenterology  1997;113;2  Link to Arginine vasopressin induces contraction and stimulates growth of cultured human hepatic stellate cells.
  142. Journal Article Ruiz-del-Arbol L, Monescillo A, Jimenéz W, Garcia-Plaza A, Arroyo V, Rodés J. Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.  Gastroenterology  1997;113;2  Link to Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis.
  143. Journal ArticleReview Ginès P, Fernández-Esparrach G, Arroyo V. Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment.  Baillieres Clin. Gastroenterol.  1997;11;2  Link to Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment.
  144. Journal Article Saló J, Guevara M, Fernández-Esparrach G, Bataller R, Ginès A, Jimenez W, Ginès P, Rivera F, Arroyo V, Rodés J. Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.  Hepatology  1997;25;6  Link to Impairment of renal function during moderate physical exercise in cirrhotic patients with ascites: relationship with the activity of neurohormonal systems.
  145. Journal Article Morales-Ruiz M, Jiménez W, Ros J, Solé M, Leivas A, Bosch-Marcé M, Rivera F, Arroyo V, Rodés J. Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis.  Gastroenterology  1997;112;6  Link to Nitric oxide production by peritoneal macrophages of cirrhotic rats: a host response against bacterial peritonitis.
  146. Journal ArticleReview Ginès P, Arroyo V, Rodès J. Pathophysiology, complications, and treatment of ascites.  Clin Liver Dis  1997;1;1  Link to Pathophysiology, complications, and treatment of ascites.
  147. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Fernández-Esparrach G, Guevara M, Sort P, Pardo A, Jiménez W, Ginès P, Planas R, Lebrec D, Geuvel A, Elewaut A, Adler M, Arroyo V. Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.  J. Hepatol.  1997;26;3  Link to Diuretic requirements after therapeutic paracentesis in non-azotemic patients with cirrhosis. A randomized double-blind trial of spironolactone versus placebo.
  148. Journal ArticleReview Sort P, Guevara M, Arroyo V. [Hyperaldosteronism, spironolactone and liver cirrhosis]  Gastroenterol Hepatol  1997;20;3  Link to [Hyperaldosteronism, spironolactone and liver cirrhosis]
  149. Clinical TrialControlled Clinical TrialJournal Article Badalamenti S, Salerno F, Salmeron JM, Lorenzano E, Rimola A, Ginés P, Jimenez W, Graziani G, Arroyo V, Rodes J, Ponticelli C. Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration.  Hepatology  1997;25;2  Link to Lack of renal effects of fish oil administration in patients with advanced cirrhosis and impaired glomerular filtration.
  150. Journal Article Llovet JM, Rodríguez-Iglesias P, Moitinho E, Planas R, Bataller R, Navasa M, Menacho M, Pardo A, Castells A, Cabré E, Arroyo V, Gassull MA, Rodés J. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.  J. Hepatol.  1997;26;1  Link to Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes.
  151. Journal ArticleReview Bataller R, Ginès P, Guevara M, Arroyo V. Hepatorenal syndrome.  Semin. Liver Dis.  1997;17;3  Link to Hepatorenal syndrome.
  152. Journal ArticleReview Ginès P, Fernández-Esparrach G, Arroyo V, Rodés J. Pathogenesis of ascites in cirrhosis.  Semin. Liver Dis.  1997;17;3  Link to Pathogenesis of ascites in cirrhosis.
  153. Journal Article Ros J, Leivas A, Jiménez W, Morales M, Bosch-Marcé M, Arroyo V, Rivera F, Rodés J. Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells.  J. Hepatol.  1997;26;1  Link to Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells.

    154. 1996

  154. Journal Article Saló J, Ginès A, Quer JC, Fernández-Esparrach G, Guevara M, Ginès P, Bataller R, Planas R, Jiménez W, Arroyo V, Rodés J. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.  J. Hepatol.  1996;25;6  Link to Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.
  155. Comparative StudyJournal Article Saló J, Jiménez W, Kuhn M, Ginès A, Ginès P, Fernández-Esparrach G, Angeli P, Clària J, Bataller R, Arroyo V, Forssmann WG, Rodés J. Urinary excretion of urodilatin in patients with cirrhosis.  Hepatology  1996;24;6  Link to Urinary excretion of urodilatin in patients with cirrhosis.
  156. Journal Article Morales-Ruiz M, Jiménez W, Pérez-Sala D, Ros J, Leivas A, Lamas S, Rivera F, Arroyo V. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites.  Hepatology  1996;24;6  Link to Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites.
  157. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Navasa M, Follo A, Llovet JM, Clemente G, Vargas V, Rimola A, Marco F, Guarner C, Forné M, Planas R, Bañares R, Castells L, Jimenez De Anta MT, Arroyo V, Rodés J. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.  Gastroenterology  1996;111;4  Link to Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
  158. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Solà R, Ginès P, Terg R, Inglada L, Vaqué P, Salerno F, Vargas V, Clemente G, Quer JC, Jiménez W, Arroyo V, Rodés J. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.  Gastroenterology  1996;111;4  Link to Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.
  159. EditorialReview Arroyo V, Ginès P. TIPS and refractory ascites. Lessons from the recent history of ascites therapy.  J. Hepatol.  1996;25;2  Link to TIPS and refractory ascites. Lessons from the recent history of ascites therapy.
  160. Case ReportsJournal Article Arroyo V, Fernández-Esparrach G, Ginès P. Diagnostic approach to the cirrhotic patient with ascites.  J. Hepatol.  1996;25 Suppl 1  Link to Diagnostic approach to the cirrhotic patient with ascites.
  161. Consensus Development ConferenceJournal ArticleReview Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.  Hepatology  1996;23;1  Link to Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.

    162. 1995

  162. Clinical TrialJournal ArticleRandomized Controlled Trial Luca A, García-Pagán JC, Bosch J, Feu F, Jiménez W, Ginés A, Fernández M, Escorsell A, Arroyo V, Rodés J. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.  Hepatology  1995;22;3  Link to Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.
  163. Journal Article Ros J, Clària J, Jiménez W, Bosch-Marcé M, Angeli P, Arroyo V, Rivera F, Rodés J. Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis.  Hepatology  1995;22;3  Link to Role of nitric oxide and prostacyclin in the control of renal perfusion in experimental cirrhosis.
  164. Journal Article Saló J, Ginès A, Anibarro L, Jiménez W, Bataller R, Clària J, Ginès P, Rivera F, Arroyo V, Rodés J. Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels.  Hepatology  1995;22;2  Link to Effect of upright posture and physical exercise on endogenous neurohormonal systems in cirrhotic patients with sodium retention and normal supine plasma renin, aldosterone, and norepinephrine levels.
  165. Comparative StudyJournal Article Bosch-Marcé M, Jiménez W, Angeli P, Leivas A, Clària J, Graziotto A, Arroyo V, Rivera F, Rodés J. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.  Gastroenterology  1995;109;1  Link to Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
  166. Journal Article Leivas A, Jiménez W, Lamas S, Bosch-Marcé M, Oriola J, Clària J, Arroyo V, Rivera F, Rodés J. Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites.  Gastroenterology  1995;108;6  Link to Endothelin 1 does not play a major role in the homeostasis of arterial pressure in cirrhotic rats with ascites.
  167. Clinical TrialJournal ArticleRandomized Controlled TrialReview Planas R, Arroyo V. Spontaneous bacterial peritonitis.  Acta Gastroenterol. Belg.  1995;58;3-4  Link to Spontaneous bacterial peritonitis.
  168. Journal Article Saló J, Francitorra A, Follo A, Navasa M, Ginès A, Jiménez W, Ginès P, Arroyo V, Rivera F, Rodés J. Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume.  J. Hepatol.  1995;22;4  Link to Increased plasma endothelin in cirrhosis. Relationship with systemic endotoxemia and response to changes in effective blood volume.
  169. Clinical TrialJournal ArticleRandomized Controlled Trial Solà R, Andreu M, Coll S, Vila MC, Oliver MI, Arroyo V. Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: results of a randomized study.  Hepatology  1995;21;2  Link to Spontaneous bacterial peritonitis in cirrhotic patients treated using paracentesis or diuretics: results of a randomized study.
  170. Journal Article Ros J, Jiménez W, Lamas S, Clària J, Arroyo V, Rivera F, Rodés J. Nitric oxide production in arterial vessels of cirrhotic rats.  Hepatology  1995;21;2  Link to Nitric oxide production in arterial vessels of cirrhotic rats.

    171. 1994

  171. Journal Article Follo A, Llovet JM, Navasa M, Planas R, Forns X, Francitorra A, Rimola A, Gassull MA, Arroyo V, Rodés J. Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.  Hepatology  1994;20;6  Link to Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis.
  172. In VitroJournal Article Clària J, Jiménez W, Ros J, Rigol M, Angeli P, Arroyo V, Rivera F, Rodés J. Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites.  Hepatology  1994;20;6  Link to Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites.
  173. Clinical TrialJournal Article Maroto A, Ginès A, Saló J, Clària J, Ginès P, Anibarro L, Jiménez W, Arroyo V, Rodés J. Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.  Hepatology  1994;20;4 Pt 1  Link to Diagnosis of functional kidney failure of cirrhosis with Doppler sonography: prognostic value of resistive index.
  174. Journal Article Angeli P, Jiménez W, Arroyo V, Mackenzie HS, Zhang PL, Clària J, Rivera F, Brenner BM, Rodés J. Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.  Hepatology  1994;20;4 Pt 1  Link to Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.
  175. Journal Article Arroyo V, Ginès A, Saló J. A European survey on the treatment of ascites in cirrhosis.  J. Hepatol.  1994;21;4  Link to A European survey on the treatment of ascites in cirrhosis.
  176. Journal Article Castro A, Ros J, Jiménez W, Clària J, Llibre J, Leivas A, Arroyo V, Rivera F, Rodés J. Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis.  J. Hepatol.  1994;21;4  Link to Intracellular calcium concentration in vascular smooth muscle cells of rats with cirrhosis.
  177. Journal Article Castells A, Saló J, Planas R, Quer JC, Ginès A, Boix J, Ginès P, Gassull MA, Terés J, Arroyo V. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.  Hepatology  1994;20;3  Link to Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis: a retrospective study.
  178. Journal Article Luca A, Feu F, García-Pagán JC, Jiménez W, Arroyo V, Bosch J, Rodés J. Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites.  Hepatology  1994;20;1 Pt 1  Link to Favorable effects of total paracentesis on splanchnic hemodynamics in cirrhotic patients with tense ascites.
  179. Journal Article Balasch J, Arroyo V, Fábregues F, Saló J, Jiménez W, Paré JC, Vanrell JA. Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome.  Ann. Intern. Med.  1994;121;1  Link to Neurohormonal and hemodynamic changes in severe cases of the ovarian hyperstimulation syndrome.
  180. Journal Article García-Pagán JC, Salmerón JM, Feu F, Luca A, Ginés P, Pizcueta P, Claria J, Piera C, Arroyo V, Bosch J. Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.  Hepatology  1994;19;5  Link to Effects of low-sodium diet and spironolactone on portal pressure in patients with compensated cirrhosis.
  181. Journal Article Asbert M, Clària J, Jiménez W, Arroyo V, Ros J, Gaya J, Rivera F, Rodés J. Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis.  J. Hepatol.  1994;20;5  Link to Blunted natriuretic response to human urine extracts with Na+,K(+)-ATPase inhibiting activity in experimental cirrhosis.
  182. Journal ArticleReview Forns X, Ginès A, Ginès P, Arroyo V. Management of ascites and renal failure in cirrhosis.  Semin. Liver Dis.  1994;14;1  Link to Management of ascites and renal failure in cirrhosis.
  183. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Solà R, Vila MC, Andreu M, Oliver MI, Coll S, Gana J, Ledesma S, Ginès P, Jiménez W, Arroyo V. Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.  J. Hepatol.  1994;20;2  Link to Total paracentesis with dextran 40 vs diuretics in the treatment of ascites in cirrhosis: a randomized controlled study.
  184. Journal ArticleReview Arroyo V, Clària J, Saló J, Jiménez W. Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites.  Semin. Liver Dis.  1994;14;1  Link to Antidiuretic hormone and the pathogenesis of water retention in cirrhosis with ascites.
  185. Journal ArticleReview Arroyo V, Navasa M, Rimola A. Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.  Infection  1994;22 Suppl 3  Link to Spontaneous bacterial peritonitis in liver cirrhosis: treatment and prophylaxis.

    186. 1993

  186. In VitroJournal Article Castro A, Jiménez W, Clària J, Ros J, Martínez JM, Bosch M, Arroyo V, Piulats J, Rivera F, Rodés J. Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide.  Hepatology  1993;18;2  Link to Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide.
  187. Journal Article Ginès A, Escorsell A, Ginès P, Saló J, Jiménez W, Inglada L, Navasa M, Clària J, Rimola A, Arroyo V. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.  Gastroenterology  1993;105;1  Link to Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites.
  188. CommentLetter Badalamenti S, Gines P, Arroyo V. Renal effects of amino acid administration in cirrhosis.  Gastroenterology  1993;104;6  Link to Renal effects of amino acid administration in cirrhosis.
  189. Journal ArticleReview Jiménez W, Arroyo V. Pathogenesis of sodium retention in cirrhosis.  J. Hepatol.  1993;18;2  Link to Pathogenesis of sodium retention in cirrhosis.
  190. Journal ArticleReview Inglada L, Saló J, Arroyo V. [Neuropeptide Y: a new important endogenous vasoconstrictor in circulatory homeostasis]  Med Clin (Barc)  1993;100;19  Link to [Neuropeptide Y: a new important endogenous vasoconstrictor in circulatory homeostasis]
  191. Journal Article Salmerón JM, Ruiz del Arbol L, Ginès A, García-Pagán JC, Ginès P, Feu F, Claria J, Rivera F, Bosch J, Arroyo V. Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.  Hepatology  1993;17;5  Link to Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis.
  192. Journal Article Maroto A, Ginès P, Arroyo V, Ginès A, Saló J, Clària J, Jiménez W, Bru C, Rivera F, Rodés J. Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction.  Hepatology  1993;17;5  Link to Brachial and femoral artery blood flow in cirrhosis: relationship to kidney dysfunction.
  193. Journal Article Asbert M, Ginès A, Ginès P, Jiménez W, Clària J, Saló J, Arroyo V, Rivera F, Rodés J. Circulating levels of endothelin in cirrhosis.  Gastroenterology  1993;104;5  Link to Circulating levels of endothelin in cirrhosis.
  194. Journal ArticleReview Arroyo V, Ginés P, Navasa M, Rimola A. Renal failure in cirrhosis and liver transplantation.  Transplant. Proc.  1993;25;2  Link to Renal failure in cirrhosis and liver transplantation.
  195. Journal Article Ginès A, Salmerón JM, Ginès P, Arroyo V, Jiménez W, Rivera F, Rodés J. Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.  J. Hepatol.  1993;17;2  Link to Oral misoprostol or intravenous prostaglandin E2 do not improve renal function in patients with cirrhosis and ascites with hyponatremia or renal failure.
  196. Journal Article Toledo C, Salmerón JM, Rimola A, Navasa M, Arroyo V, Llach J, Ginès A, Ginès P, Rodés J. Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.  Hepatology  1993;17;2  Link to Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime.
  197. Journal ArticleReview Arroyo V, Ginès P. Mechanism of sodium retention and ascites formation in cirrhosis.  J. Hepatol.  1993;17 Suppl 2  Link to Mechanism of sodium retention and ascites formation in cirrhosis.
  198. Journal ArticleReview Ginès P, Arroyo V. Paracentesis in the management of cirrhotic ascites.  J. Hepatol.  1993;17 Suppl 2  Link to Paracentesis in the management of cirrhotic ascites.
  199. Journal Article Llach J, Ginès P, Arroyo V, Salmerón JM, Ginès A, Jiménez W, Gaya J, Rivera F, Rodés J. Effect of dipyridamole on kidney function in cirrhosis.  Hepatology  1993;17;1  Link to Effect of dipyridamole on kidney function in cirrhosis.

    200. 1992

  200. Journal Article Ginès A, Salmerón JM, Ginès P, Jiménez W, Saló J, Piera C, Clària J, Rivera F, Arroyo V, Rodés J. Effects of somatostatin on renal function in cirrhosis.  Gastroenterology  1992;103;6  Link to Effects of somatostatin on renal function in cirrhosis.
  201. Journal Article Llach J, Rimola A, Navasa M, Ginès P, Salmerón JM, Ginès A, Arroyo V, Rodés J. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.  Hepatology  1992;16;3  Link to Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration.
  202. Journal Article La Villa G, Salmerón JM, Arroyo V, Bosch J, Ginés P, García-Pagán JC, Ginés A, Asbert M, Jiménez W, Rivera F. Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.  Gastroenterology  1992;102;6  Link to Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.
  203. Comparative StudyJournal Article Asbert M, Jiménez W, Gaya J, Ginés P, Arroyo V, Rivera F, Rodés J. Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.  J. Hepatol.  1992;15;1-2  Link to Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin.
  204. Journal ArticleReview Arroyo V, Ginès P, Planas R. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.  Gastroenterol. Clin. North Am.  1992;21;1  Link to Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
  205. CommentEditorial Arroyo V, Ginés P. Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis.  Gastroenterology  1992;102;3  Link to Arteriolar vasodilation and the pathogenesis of the hyperdynamic circulation and renal sodium and water retention in cirrhosis.
  206. Clinical TrialComparative StudyJournal Article Salmerón JM, Titó L, Rimola A, Mas A, Navasa MA, Llach J, Ginès A, Ginès P, Arroyo V, Rodés J. Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure.  J. Hepatol.  1992;14;2-3  Link to Selective intestinal decontamination in the prevention of bacterial infection in patients with acute liver failure.
  207. English AbstractJournal Article Toledo C, Ginés P, Arroyo V. [Liver cirrhosis: pathogenesis of ascites and disturbance of renal function]  Rev Med Chil  1992;120;2  Link to [Liver cirrhosis: pathogenesis of ascites and disturbance of renal function]
  208. Journal Article Clària J, Jiménez W, Ros J, Asbert M, Castro A, Arroyo V, Rivera F, Rodés J. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide.  Hepatology  1992;15;2  Link to Pathogenesis of arterial hypotension in cirrhotic rats with ascites: role of endogenous nitric oxide.
  209. Journal Article Ginès P, Titó L, Arroyo V, Llach J, Salmerón JM, Ginès A, Jiménez W, Badalamenti S, Rivera F, Rodés J. Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.  Gastroenterology  1992;102;1  Link to Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure.
  210. Journal ArticleReview Jiménez W, Clária J, Arroyo V, Rodés J. Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease.  J. Gastroenterol. Hepatol.  1992;7;1  Link to Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease.

    211. 1991

  211. In VitroJournal Article Jiménez W, Gutkowska J, Ginés P, Arroyo V, Rivera F, Rodés J. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.  Hepatology  1991;14;4 Pt 1  Link to Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
  212. Clinical TrialComparative StudyJournal ArticleMulticenter StudyRandomized Controlled Trial Ginès P, Arroyo V, Vargas V, Planas R, Casafont F, Panés J, Hoyos M, Viladomiu L, Rimola A, Morillas R. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.  N. Engl. J. Med.  1991;325;12  Link to Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
  213. Journal ArticleReview Wilkinson SP, Moore KP, Arroyo V. Pathogenesis of ascites and hepatorenal syndrome.  Gut  1991;Suppl  Link to Pathogenesis of ascites and hepatorenal syndrome.
  214. Journal Article López C, Jiménez W, Arroyo V, Clària J, La Villa G, Asbert M, Gaya J, Rivera F, Rodés J. Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride-induced cirrhosis.  Hepatology  1991;13;3  Link to Temporal relationship between the decrease in arterial pressure and sodium retention in conscious spontaneously hypertensive rats with carbon tetrachloride-induced cirrhosis.
  215. Journal Article Claria J, Jimenez W, La Villa G, Asbert M, Castro A, Llibre JL, Arroyo V, Rivera F. Effects of endothelin on renal haemodynamics and segmental sodium handling in conscious rats.  Acta Physiol. Scand.  1991;141;3  Link to Effects of endothelin on renal haemodynamics and segmental sodium handling in conscious rats.
  216. Journal Article Claria J, Jiménez W, Arroyo V, La Villa G, López C, Asbert M, Castro A, Gaya J, Rivera F, Rodés J. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.  Gastroenterology  1991;100;2  Link to Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.
  217. English AbstractJournal Article Llach J, Rimola A, Arroyo V, García Valdecasas JC, Grande L, Visa J, Navasa MA, Mas A, Ginès P, Fuster J. [Liver transplantation: candidate selection and results of a program for adult patients]  Med Clin (Barc)  1991;96;2  Link to [Liver transplantation: candidate selection and results of a program for adult patients]

    218. 1990

  218. Clinical TrialJournal ArticleRandomized Controlled Trial Planas R, Ginès P, Arroyo V, Llach J, Panés J, Vargas V, Salmerón JM, Ginès A, Toledo C, Rimola A. Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.  Gastroenterology  1990;99;6  Link to Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study.
  219. Journal ArticleReview Arroyo V, Ginés P. Prostaglandins and the treatment of hepatorenal syndrome in cirrhosis.  J. Hepatol.  1990;11;2  Link to Prostaglandins and the treatment of hepatorenal syndrome in cirrhosis.
  220. Comparative StudyJournal Article Asbert M, Jiménez W, La Villa G, Clària J, López C, Ginés P, Gaya J, Castro A, Rivera F, Arroyo V. Urinary excretion of endogenous digitalis-like natriuretic substances in healthy subjects. Effect of sodium load.  Rev. Esp. Fisiol.  1990;46;3  Link to Urinary excretion of endogenous digitalis-like natriuretic substances in healthy subjects. Effect of sodium load.
  221. Case ReportsJournal Article Ginès A, Llach J, Calvet X, Bruix J, Arroyo V, Rodés J. Neck "ascites" after peritoneovenous shunt.  J. Clin. Gastroenterol.  1990;12;3  Link to Neck "ascites" after peritoneovenous shunt.
  222. Journal ArticleReview La Villa G, Arroyo V. Pathophysiology and treatment of ascites in cirrhosis.  Trop Gastroenterol  1990;11;2  Link to Pathophysiology and treatment of ascites in cirrhosis.
  223. Journal Article Badalamenti S, Ginés P, Arroyo V, Llach J, Piera C, Rimola A, Jiménez W, Gaya J, Casamitjana R, Rivera F. Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis.  Hepatology  1990;11;3  Link to Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis.
  224. Comparative StudyJournal Article Arroyo V. Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.  Acta Gastroenterol. Belg.  1990;53;2  Link to Diuretic-resistant ascites in cirrhosis. Mechanism and treatment.
  225. Journal Article Titó L, Ginès P, Arroyo V, Planas R, Panés J, Rimola A, Llach J, Humbert P, Badalamenti S, Jiménez W. Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.  Gastroenterology  1990;98;1  Link to Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites.

    226. 1989

  226. Journal ArticleReview Llach J, Ginés P, Arroyo V. [Refractory ascites in liver cirrhosis. Pathogenesis and treatment]  Med Clin (Barc)  1989;93;16  Link to [Refractory ascites in liver cirrhosis. Pathogenesis and treatment]
  227. Journal Article Guarner F, Wallace JL, MacNaughton WK, Ibbotson GC, Arroyo V, Rodés J. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor.  Hepatology  1989;10;5  Link to Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor.
  228. Journal Article Claria J, Jiménez W, Arroyo V, Guarner F, López C, La Villa G, Asbert M, Rivera F, Rodés J. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.  Gastroenterology  1989;97;5  Link to Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
  229. Journal Article López C, Jiménez W, Arroyo V, La Villa G, Gaya J, Clària J, Rivera F, Rodés J. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.  J. Hepatol.  1989;9;2  Link to Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites.
  230. Journal ArticleReview Ginès P, Arroyo V, Rodés J. Treatment of ascites and renal failure in cirrhosis.  Baillieres Clin. Gastroenterol.  1989;3;1  Link to Treatment of ascites and renal failure in cirrhosis.

    231. 1988

  231. Journal Article Jiménez W, Martínez-Pardo A, Arroyo V, Gaya J, Rivera F. Effect of spironolactone on the renin-aldosterone system in rats.  Rev. Esp. Fisiol.  1988;44;3  Link to Effect of spironolactone on the renin-aldosterone system in rats.
  232. Journal Article Solà J, Camps J, Arroyo V, Guarner F, Gaya J, Rivera F, Rodes J. Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system.  Clinical science (London, England : 1979)  1988;75;3  Link to Longitudinal study of renal prostaglandin excretion in cirrhotic rats: relationship with the renin-aldosterone system.
  233. Journal Article López C, Jiménez W, Arroyo V, Gaya J, Rivera F, Rodés J. Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.  Rev. Esp. Fisiol.  1988;44;3  Link to Effect of atrial natriuretic peptide on arterial pressure and renal function in cirrhotic rats with ascites.
  234. Journal ArticleReview Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodés J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.  Hepatology  1988;8;5  Link to Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis.
  235. Comparative StudyJournal Article Camps J, Sola X, Rimola A, Parés A, Rives A, Salmeron JM, Arroyo V, Rodés J. Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis.  Hepatology  1988;8;4  Link to Comparative study of aminoglycoside nephrotoxicity in normal rats and rats with experimental cirrhosis.
  236. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Ginès P, Titó L, Arroyo V, Planas R, Panés J, Viver J, Torres M, Humbert P, Rimola A, Llach J. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.  Gastroenterology  1988;94;6  Link to Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.
  237. Journal Article Rimola A, Ginés P, Cusó E, Camps J, Gaya J, Arroyo V, Rodés J. Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure.  Clinical science (London, England : 1979)  1988;74;6  Link to Prostaglandin precursor fatty acids in cirrhosis with ascites: effect of linoleic acid infusion in functional renal failure.
  238. Comparative StudyJournal Article Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó L, Serra A, Bosch J, Sanz G, Rivera F. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction.  Hepatology  1988;8;3  Link to Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction.
  239. Journal ArticleReview Arroyo V, Bernardi M, Epstein M, Henriksen JH, Schrier RW, Rodés J. Pathophysiology of ascites and functional renal failure in cirrhosis.  J. Hepatol.  1988;6;2  Link to Pathophysiology of ascites and functional renal failure in cirrhosis.
  240. Journal Article Llach J, Ginès P, Arroyo V, Rimola A, Titó L, Badalamenti S, Jiménez W, Gaya J, Rivera F, Rodés J. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.  Gastroenterology  1988;94;2  Link to Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites.
  241. Journal Article Titó L, Rimola A, Ginès P, Llach J, Arroyo V, Rodés J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.  Hepatology  1988;8;1  Link to Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors.

    242. 1987

  242. Journal Article Camps J, Solá J, Arroyo V, Pérez-Ayuso RM, Gaya J, Rivera F, Rodés J. Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis.  Gastroenterology  1987;93;3  Link to Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis.
  243. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Ginés P, Arroyo V, Quintero E, Planas R, Bory F, Cabrera J, Rimola A, Viver J, Camps J, Jiménez W. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.  Gastroenterology  1987;93;2  Link to Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
  244. Journal Article Arroyo V, Ginés P. [Treatment of cirrhotic ascites. Paracentesis again?]  Med Clin (Barc)  1987;89;3  Link to [Treatment of cirrhotic ascites. Paracentesis again?]
  245. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Heredia D, Caballería J, Arroyo V, Ravelli G, Rodés J. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.  J. Hepatol.  1987;4;3  Link to Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
  246. Journal Article Arroyo V, Badalamenti S, Ginès P. Refractory ascites: definition and mechanism.  Minerva Med.  1987;78;10  Link to Refractory ascites: definition and mechanism.
  247. Journal Article Arroyo V, Badalamenti S, Ginès P. Pathogenesis of ascites in cirrhosis.  Minerva Med.  1987;78;10  Link to Pathogenesis of ascites in cirrhosis.
  248. English AbstractJournal Article Rodés J, Arroyo V. [Physiopathology and treatment of ascites in the cirrhotic patient]  Rev Med Brux  1987;8;4  Link to [Physiopathology and treatment of ascites in the cirrhotic patient]
  249. Journal Article Ginés P, Quintero E, Arroyo V, Terés J, Bruguera M, Rimola A, Caballería J, Rodés J, Rozman C. Compensated cirrhosis: natural history and prognostic factors.  Hepatology  1987;7;1  Link to Compensated cirrhosis: natural history and prognostic factors.

    250. 1986

  250. Journal ArticleReview Arroyo V, Ginés P, Planas R, Panés J, Rodés J. Management of patients with cirrhosis and ascites.  Semin. Liver Dis.  1986;6;4  Link to Management of patients with cirrhosis and ascites.
  251. English AbstractJournal Article Camps J, Solá J, Arroyo V, Gaya J, Rimola A, Rodés J, Rivera F. [Determination of arginine-vasopressin in small volumes of rat plasma]  Rev. Esp. Fisiol.  1986;42;3  Link to [Determination of arginine-vasopressin in small volumes of rat plasma]
  252. Journal ArticleReview Arroyo V, Ginés P, Rimola A, Gaya J. Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis.  Am. J. Med.  1986;81;2B  Link to Renal function abnormalities, prostaglandins, and effects of nonsteroidal anti-inflammatory drugs in cirrhosis with ascites. An overview with emphasis on pathogenesis.
  253. Journal Article Jiménez W, Martinez-Pardo A, Arroyo V, Gaya J, Rivera F, Rodés J. Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites.  Am. J. Physiol.  1986;250;4 Pt 2  Link to Atrial natriuretic factor: reduced cardiac content in cirrhotic rats with ascites.
  254. English AbstractJournal Article Camps J, Solá J, Arroyo V, Rimola A, Pérez-Ayuso RM, Gaya J, Rivera F, Rodés J. [Technics for the study of the renal excretion of free water in normal rats and those with experimental liver cirrhosis]  Rev. Esp. Fisiol.  1986;42;1  Link to [Technics for the study of the renal excretion of free water in normal rats and those with experimental liver cirrhosis]
  255. Journal ArticleReview Arroyo V, Ginés P, Rodés J. Treatment of ascites in patients with cirrhosis of the liver.  J. Hepatol.  1986;2;3  Link to Treatment of ascites in patients with cirrhosis of the liver.
  256. Journal Article Rimola A, Ginés P, Arroyo V, Camps J, Pérez-Ayuso RM, Quintero E, Gaya J, Rivera F, Rodés J. Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).  J. Hepatol.  1986;3;1  Link to Urinary excretion of 6-keto-prostaglandin F1 alpha, thromboxane B2 and prostaglandin E2 in cirrhosis with ascites. Relationship to functional renal failure (hepatorenal syndrome).
  257. Letter Arroyo V, Rimola A, Felisart J, Cabrera J. Urinary beta 2-microglobulin and serum bilirubin concentrations in hepatorenal syndrome and acute tubular necrosis.  Hepatology  1986;6;1  Link to Urinary beta 2-microglobulin and serum bilirubin concentrations in hepatorenal syndrome and acute tubular necrosis.
  258. Journal ArticleReview Arroyo V, Rimola A, Gaya J, Rodés J. Prostaglandins and renal function in cirrhosis.  Prog Liver Dis  1986;8  Link to Prostaglandins and renal function in cirrhosis.

    259. 1985

  259. Comparative StudyEnglish AbstractJournal Article Jiménez W, Martínez-Pardo A, Arroyo V, López C, Rímola A, Gaya J, Rivera F. [Effect of the method of blood extraction on plasma levels of renin in the Wistar rat]  Rev. Esp. Fisiol.  1985;41;3  Link to [Effect of the method of blood extraction on plasma levels of renin in the Wistar rat]
  260. Journal Article Esmatjes E, Fernandez MR, Halperin I, Camps J, Gaya J, Arroyo V, Rivera F, Figuerola D. Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.  J. Clin. Endocrinol. Metab.  1985;60;6  Link to Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.
  261. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Felisart J, Rimola A, Arroyo V, Perez-Ayuso RM, Quintero E, Gines P, Rodes J. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.  Hepatology  1985;5;3  Link to Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.
  262. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage.  Hepatology  1985;5;3  Link to Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage.
  263. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Quintero E, Ginés P, Arroyo V, Rimola A, Bory F, Planas R, Viver J, Cabrera J, Rodés J. Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.  Lancet  1985;1;8429  Link to Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites.
  264. Journal Article Jiménez W, Martinez-Pardo A, Arroyo V, Bruix J, Rimola A, Gaya J, Rivera F, Rodés J. Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis.  Hepatology  1985;5;2  Link to Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis.
  265. Journal Article Arroyo V, Rodés J. [Is a low-sodium diet necessary in patients with ascites?]  Presse Med  1985;14;4  Link to [Is a low-sodium diet necessary in patients with ascites?]

    266. 1984

  266. English AbstractJournal Article Camps J, Solá J, Rimola A, Arroyo V, Ballesta A, Rodés J. [Determination of the concentration of gentamycin in the renal tissue of rats by radioimmunoassay]  Arch Farmacol Toxicol  1984;10;3  Link to [Determination of the concentration of gentamycin in the renal tissue of rats by radioimmunoassay]
  267. Journal Article Pérez-Ayuso RM, Arroyo V, Camps J, Rimola A, Costa J, Gaya J, Rivera F, Rodés J. Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.  Hepatology  1984;4;2  Link to Renal kallikrein excretion in cirrhotics with ascites: relationship to renal hemodynamics.
  268. Journal Article Rimola A, Soto R, Bory F, Arroyo V, Piera C, Rodes J. Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.  Hepatology  1984;4;1  Link to Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.

    269. 1983

  269. English AbstractJournal Article Camps J, Costa J, Pérez-Ayuso RM, Rimola A, Arroyo V, Gaya J. [Specificity of the determination of urinary kallikrein activity using an amidolytic assay]  Rev. Esp. Fisiol.  1983;39;3  Link to [Specificity of the determination of urinary kallikrein activity using an amidolytic assay]
  270. Journal Article Arroyo V, Planas R, Gaya J, Deulofeu R, Rimola A, Pérez-Ayuso RM, Rivera F, Rodés J. Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.  Eur. J. Clin. Invest.  1983;13;3  Link to Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.
  271. Clinical TrialComparative StudyJournal ArticleRandomized Controlled Trial Pérez-Ayuso RM, Arroyo V, Planas R, Gaya J, Bory F, Rimola A, Rivera F, Rodés J. Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.  Gastroenterology  1983;84;5 Pt 1  Link to Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.
  272. Journal Article Planas R, Arroyo V, Rimola A, Pérez-Ayuso RM, Rodés J. Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.  Gastroenterology  1983;84;2  Link to Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.

    273. 1982

  273. Case ReportsEnglish AbstractJournal Article Ribera JM, Urbano-Márquez A, Arroyo V, Bosch J, Estruch R, Grau JM. [Portal hypertension, ascites and functional renal insufficiency in a patient with agnogenic myeloid metaplasia]  Med Clin (Barc)  1982;79;10  Link to [Portal hypertension, ascites and functional renal insufficiency in a patient with agnogenic myeloid metaplasia]
  274. Journal Article Cabrera J, Arroyo V, Ballesta AM, Rimola A, Gual J, Elena M, Rodes J. Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.  Gastroenterology  1982;82;1  Link to Aminoglycoside nephrotoxicity in cirrhosis. Value of urinary beta 2-microglobulin to discriminate functional renal failure from acute tubular damage.

    275. 1981

  275. Journal Article Mas A, Bosch J, Piera C, Arroyo V, Setoain J, Rodes J. Intracellular and exchangeable potassium in cirrhosis. Evidence against the occurrence of potassium depletion in cirrhosis with ascites.  Dig. Dis. Sci.  1981;26;8  Link to Intracellular and exchangeable potassium in cirrhosis. Evidence against the occurrence of potassium depletion in cirrhosis with ascites.
  276. Journal Article Arroyo V, Bosch J, Mauri M, Ribera F, Navarro-López F, Rodés J. Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.  Eur. J. Clin. Invest.  1981;11;3  Link to Effect of angiotensin-II blockade on systemic and hepatic haemodynamics and on the renin-angiotensin-aldosterone system in cirrhosis with ascites.
  277. Journal Article Arroyo V, Bosch J, Gaya-Beltrán J, Kravetz D, Estrada L, Rivera F, Rodés J. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.  Ann. Intern. Med.  1981;94;2  Link to Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites.

    278. 1980

  278. Journal Article Arroyo V, Bosch J, Casamitjana R, Cabrera J, Rivera F, Rodés J. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.  Gut  1980;21;10  Link to Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
  279. Journal Article Bosch J, Arroyo V, Betriu A, Mas A, Carrilho F, Rivera F, Navarro-Lopez F, Rodes J. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.  Gastroenterology  1980;78;1  Link to Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.

    280. 1979

  280. Case ReportsEnglish AbstractJournal Article Xaubet A, Aranguibel F, Cecilia A, Arroyo V, Bosch J, Rodés J, Gibert-Queraltó J. [Treatment of the syndrome of inappropriate antidiuretic hormone secretion with demethylchlortetracycline (author's transl)]  Med Clin (Barc)  1979;72;8  Link to [Treatment of the syndrome of inappropriate antidiuretic hormone secretion with demethylchlortetracycline (author's transl)]
  281. Journal Article Arroyo V, Bosch J, Mauri M, Viver J, Mas A, Rivera F, Rodes J. Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.  Eur. J. Clin. Invest.  1979;9;1  Link to Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.
  282. Journal Article Wilkinson SP, Jowett TP, Slater JD, Arroyo V, Moodie H, Williams R. Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.  Clinical science (London, England : 1979)  1979;56;2  Link to Renal sodium retention in cirrhosis: relation to aldosterone and nephron site.

    283. 1978

  283. Journal Article Bosch Y, Arroyo V, Mauri M, Rivera F, Rodes J. [Renal perfusion and the renin-angiotensin system in hepatic cirrhosis]  Minerva Med.  1978;69;47  Link to [Renal perfusion and the renin-angiotensin system in hepatic cirrhosis]

    284. 1977

  284. Journal Article Carrilho F, Bosch J, Arroyo V, Mas A, Viver J, Rodes J. Renal failure associated with demeclocycline in cirrhosis.  Ann. Intern. Med.  1977;87;2  Link to Renal failure associated with demeclocycline in cirrhosis.
  285. Journal Article Clemente C, Bosch J, Rodés J, Arroyo V, Mas A, Maragall S. Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis.  Gut  1977;18;7  Link to Functional renal failure and haemorrhagic gastritis associated with endotoxaemia in cirrhosis.

    286. 1976

  286. Journal Article Arroyo V, Rodés J, Gutiérrez-Lizárraga MA, Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.  Am J Dig Dis  1976;21;3  Link to Prognostic value of spontaneous hyponatremia in cirrhosis with ascites.

    287. 1975

  287. Journal Article Mas A, Arroyo V, Rodés J, Bosch J. Ascites and renal failure in primary liver cell carcinoma.  Br Med J  1975;3;5984  Link to Ascites and renal failure in primary liver cell carcinoma.
  288. Journal Article Rodés J, Bosch J, Arroyo V. Clinical types and drug therapy of renal impairment in cirrhosis.  Postgrad Med J  1975;51;598  Link to Clinical types and drug therapy of renal impairment in cirrhosis.
  289. Journal Article Arroyo V, Mas A, Vilardell F. Clinical experience with the Rhône-Poulenc ascites reinfusion apparatus.  Postgrad Med J  1975;51;598  Link to Clinical experience with the Rhône-Poulenc ascites reinfusion apparatus.
  290. Journal Article Arroyo V, Rodés J. A rational approach to the treatment of ascites.  Postgrad Med J  1975;51;598  Link to A rational approach to the treatment of ascites.
  291. Journal Article Rodés J, Arroyo V, Bordas JM, Bruguera M. Hypernatremia following gastrointestinal bleeding in cirrhosis with ascites.  Am J Dig Dis  1975;20;2  Link to Hypernatremia following gastrointestinal bleeding in cirrhosis with ascites.

    292. 1974

  292. Journal Article Wilkinson SP, Arroyo V, Moodie HE, Blendis LM, Williams R. Proceedings: Renal failure and site of abnormal renal retention of sodium in fulminant hepatic failure.  Gut  1974;15;4  Link to Proceedings: Renal failure and site of abnormal renal retention of sodium in fulminant hepatic failure.
  293. Journal Article Wilkinson SP, Arroyo V, Gazzard BG, Moodie H, Williams R. Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.  Lancet  1974;1;7857  Link to Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

    294. 1973

  294. Journal Article Wilkinson SP, Arroyo V, Williams R, Blendis LM. Letter: Ascites and oedema in liver disease.  Br Med J  1973;4;5886  Link to Letter: Ascites and oedema in liver disease.
Back to page of Arroyo, Vicente.

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.